drugset / Trial / NCT04585334

Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain

NCT04585334

Phase 4 Unknown 300 enrolled Fidia Farmaceutici s.p.a.
RandomizedParallel-groupDouble-blindTreatment

Summary

PAES, double blind, double dummy, multicenter, randomized, controlled clinical study to demonstrate superiority of Tricortin 1000 over placebo in improvement in pain relief as change from baseline to 15 days in patients with chronic low back pain (LBP).

Timeline

Start
2019-03-25
Primary completion
2024-12
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 140 mg Topical
Subject Tricortin 1000 Unknown 2 ml Intramuscular

Indications

No indication recorded.